Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Entia Biosciences, Inc. | entiabiosciences8k011415.htm |
Exhibit 10.1
December 26th, 2014
Arthur C. Piculell Jr. and Marvin S. Hausman, CEO Entia Biosciences Inc. hereby extend Exhibit A attached hereto and made a part hereof as if fully set out herein.
|
1.
|
This agreement will be extended for one year from the above date with the interest rate of 8% from the original date of note August 13, 2013.
|
|
2.
|
In addition thereto Arthur C. Piculell Jr. will also receive a 5 year warrant for 50,000 shares with an exercise price of 50 cents. This warrant shall have a cashless exchange provision.
|
|
3.
|
All other terms shall remain the same as set forth in Exhibit A.
|
/s/ Marvin S. Hausman Dated: January 10, 2015
Marvin S. Hausman, CEO Entia Biosciences Inc.
/s/ Arthur C. Piculell Jr. Dated: January 10, 2015
Arthur C. Piculell Jr.